Press releases | WebDisclosure

Basculer en Français

11295	Companies
251011	Keywords
179944	Articles
136874	Press releases

Home
Press releases

PRESS RELEASE

published on 08/28/2026 at 07:30, 2 months 12 days ago

OSE Immunotherapeutics organisera un webcast dédié à lusvertikimab avec des leaders d’opinion le 2 septembre 2026
Webcast dédié à lusvertikimab organisé par OSE Immunotherapeutics avec des leaders d’opinion pour discuter des maladies inflammatoires chroniques de l'intestin le 2 septembre 2026

Webcast Maladies Inflammatoires OSE Immunotherapeutics Lusvertikimab Leaders D’opinion
PRESS RELEASE

published on 08/28/2026 at 07:30, 2 months 12 days ago

OSE Immunotherapeutics to host a KOL webcast dedicated to lusvertikimab on September 2, 2026
OSE Immunotherapeutics to host KOL webcast on lusvertikimab, discussing IL-7R biology, CoTiKis trial results, and future plans on September 2, 2026

Inflammatory Bowel Diseases OSE Immunotherapeutics Lusvertikimab KOL Webcast IL-7R Biology
PRESS RELEASE

published on 08/28/2026 at 07:28, 2 months 12 days ago

EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3Y - Change of Director’s Interest Notice
Dexus Finance Pty Limited releases Appendix 3Y - Change of Director's Interest Notice for Varya Davidson, Warwick Negus AM, and Rhoda Harrington. Visit www.dexus.com/dxs for more details

ASX Dexus Finance Pty Limited Dexus Director's Interest Notice Appendix 3Y
PRESS RELEASE

published on 08/28/2026 at 07:13, 2 months 12 days ago

FamiCord significantly improves operating cash flow in Q2 2026 amid persistently challenging business environment
FamiCord AG significantly improves operating cash flow in Q2 2026 despite challenging business environment. Revenue stable at EUR 43.2 million. EBITDA down 13.8% to EUR 4.3 million

EBITDA Operating Cash Flow Revenue Stability FamiCord AG Challenging Business Environment
PRESS RELEASE

published on 08/28/2026 at 07:00, 2 months 12 days ago

Le Baloise Swiss Property Fund mène à bien une augmentation de capital de CHF 159 millions
Le Baloise Swiss Property Fund réalise avec succès une augmentation de capital de CHF 159 millions pour acquérir quatorze nouveaux biens immobiliers dans des régions dynamiques de Suisse

Suisse Baloise Immeubles Augmentation Capital Swiss Property Fund
PRESS RELEASE

published on 08/28/2026 at 07:00, 2 months 12 days ago

Edisun Power Europe AG: Challenging half-year results and resolute implementation of the new strategy
Edisun Power Europe AG reports challenging half-year results with lower solar power generation and revenues. Implements new strategy with acquisitions and issuance of 3.75% five-year bond

Acquisition Renewable Energy Edisun Power Europe AG Challenging Results Five-year Bond
PRESS RELEASE

published on 08/28/2026 at 07:00, 2 months 12 days ago

Edisun Power Europe AG:
Edisun Power Europe AG annonce des résultats semestriels difficiles avec une baisse de la production d'énergie solaire et du chiffre d'affaires. Stratégie de réorientation mise en œuvre

Chiffre D'affaires Résultats Semestriels Réorientation Stratégique Énergie Solaire Edisun Power Europe AG
PRESS RELEASE

published on 08/28/2026 at 07:00, 2 months 12 days ago

Semi-Annual Report 2026: STRABAG SE increases earnings and raises 2026 guidance
STRABAG SE increases earnings and raises 2026 guidance with a record output volume of €10 billion at half-year mark. Order backlog reaches €36 billion, EBIT up 35% to €174 million

Order Backlog Earnings STRABAG SE Output Volume 2026 Guidance
PRESS RELEASE

published on 08/28/2026 at 07:00, 2 months 12 days ago

SMT Scharf AG publishes results for the first half of 2026
SMT Scharf AG releases first half of 2026 results with revenue of EUR 33.1 million. Strategic focus on electromobility & efficiency. Forecast confirmed for 2026

Efficiency SMT Scharf AG Electromobility First Half Results EUR 33.1 Million Revenue
REGULATED PRESS RELEASE

published on 08/28/2026 at 06:55, 2 months 12 days ago

Recticel Accelerates Profitable Growth
Recticel Group reports strong financial performance in the first half of 2026, with sales increasing by 16.4% to EUR 390.1 million. Adjusted EBITDA rose by 28.9% to EUR 35.7 million

Adjusted EBITDA Financial Performance Sales Increase Recticel Group First Half 2026

Accesswire

Published on 11/06/2026 at 22:15, 2 days 11 hours ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 20 hours ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 20 hours ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 20 hours ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 2 days 23 hours ago

Mongolia Tax Audit

View all ACCESSWIRE

EQS Group

Published on 11/09/2026 at 09:00, 24 minutes ago

Cantourage further develops Telecan and strengthens digital access to medical care
Published on 11/09/2026 at 09:00, 25 minutes ago

Municipality Finance issues a GBP 50 million tap under its MTN programme
Published on 11/09/2026 at 09:00, 25 minutes ago

Municipality Finance issues EUR 47.5 million zero coupon notes under its MTN programme
Published on 11/09/2026 at 09:00, 25 minutes ago

Original-Research: EBRO MOTORS GROUP EV SA (von NuWays AG): BUY
Published on 11/09/2026 at 09:00, 25 minutes ago

Official List Notice

Les Echos

Published on 11/09/2026 at 07:00, 2 hours 25 minutes ago

bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 2 hours 25 minutes ago

BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 2 hours 25 minutes ago

Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 2 hours 25 minutes ago

bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 14 hours ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026

View all LES ECHOS COMFI WIRE